Dr. Roopa R. Rao Karlamangla
- Gender: Female
- Experience: 29 years
- Graduated from: University Of Illinois College Of Med (chi/peor/rock/chm-urb)
- Graduation year: 1992
- Sole propriator: Yes
- NPI: 1588650865
Dr. Roopa R. Rao Karlamangla M.D.
Obstetrician and Gynecologist
She is located at 1687 Erringer Road in Simi Valley, CA 93065. Can help patients with the following: Cervical Intraepithelial Neoplasia (CIN), Gynecological Exam, Polycystic Ovary Syndrome (PCOS), Premenstrual Syndrome (PMS), Sexually Transmitted Diseases (STDs), Uterine Fibroids. Her National Provider Identifier (NPI) number is 1588650865. Appointment can be made via the phone number (805) 526-6135. She is affiliated with 1 practices and 1 hospitals.
Conditions treated
Dr. Roopa Rohini Rao-Karlamangla, being an obstetrician and gynecologist, treats the following conditions. Please be advised that this list may not be complete. For the full list of conditions treated, consult directly with Dr. Roopa R. Rao Karlamangla.
- Amenorrhea
- Bacterial Vaginosis
- Birth Control Counseling
- Blood in Urine
- Braxton Hicks Contractions
- Breast Cancer
- Breastfeeding
- Breastfeeding and Lactation
- Cancer
- Cervical Cancer
- Cervical Intraepithelial Neoplasia (CIN)
- Chlamydia
- Ectopic Pregnancy
- Endometriosis
- Fibrocystic Breast Disease
- Gestational Diabetes
- Group B Streptococcal Infection (GBS)
- Gynecological Exam
- High Blood Pressure
- Hot Flashes
- Human Papillomavirus (HPV)
- Infertility
- Labor and Birth
- Menopause
- Menstrual Cramps
- Miscarriage
- Morning Sickness
- Osteoporosis
- Ovarian Cancer
- Ovarian Cysts
- Overactive Bladder (OAB)
- Pelvic Inflammatory Disease (PID)
- Pelvic Pain
- Perimenopause
- Placenta Previa
- Polycystic Ovary Syndrome (PCOS)
- Preeclampsia and Eclampsia
- Pregnancy
- Premature Ovarian Failure (POF)
- Premenstrual Dysphoric Disorder (PMDD)
- Premenstrual Syndrome (PMS)
- Prenatal Care
- Sexually Transmitted Diseases (STDs)
- Trichomoniasis
- Urinary Incontinence (UI)
- Urinary Retention
- Urinary Tract Infection (UTI)
- Uterine Cancer
- Uterine Fibroids
- Uterine Growths
- VBAC
- Vaginal Atrophy and Dryness
- Vaginal Bleeding
- Vaginal Cancer
- Vaginal Pain
- Vaginitis
- Women's Health
- Yeast Infection
Procedures Performed by Dr. Roopa R. Rao Karlamangla
Insurances Accepted by Dr. Roopa R. Rao Karlamangla
- Medicare
Payments received
Drug payment
| Pfizer | $286 |
| Noven | $46 |
| Shionogi | $18 |
Other
| Food and Beverage | $352 |
Studies
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Graduated in 1992
Looking for more Obstetrician and Gynecologists?
There are 7 other obstetrician and gynecologists in this region.
- Gender: Female
- Address: 1147 Red Tail Way Simi Valley, 93065, CA
- Gender: Female
- Address: Suite 102 1687 Erringer Road Simi Valley, 93065, CA
- Gender: Female
- Address: 1147 Red Tail Way Simi Valley, 93065, CA
- Gender: Male
- Address: 1147 Red Tail Way Simi Valley, 93065, CA
- Gender: Female
- Address: 1147 Red Tail Way Simi Valley, 93065, CA
- Gender: Male
- Address: 2840 East Los Angeles Avenue Simi Valley, 93065, CA
- Gender: Female
- Address: 1147 Red Tail Way Simi Valley, 93065, CA
Questions & Answers
Where can you meet with Dr. Roopa Rohini Rao-Karlamangla?
Dr. Roopa Rohini Rao-Karlamangla's office is located at 1687 Erringer Road in Simi Valley, CA 93065.
Has Dr. Roopa Rohini Rao-Karlamangla affiliation with hospitals?
Dr. Roopa Rohini Rao-Karlamangla is affiliated with ADVENTIST HEALTH SIMI VALLEY.
Does Dr. Roopa Rohini Rao-Karlamangla have affiliation with practices?
Dr. Roopa Rohini Rao-Karlamangla is affiliated with Roopa Rao MD.
What conditions does Dr. Roopa Rohini Rao-Karlamangla treat?
Dr. Roopa Rohini Rao-Karlamangla provides treatment for Cervical Intraepithelial Neoplasia (CIN), Gynecological Exam, Polycystic Ovary Syndrome (PCOS), Premenstrual Syndrome (PMS), Sexually Transmitted Diseases (STDs), Uterine Fibroids. For the full list see this list.
Does Dr. Roopa Rohini Rao-Karlamangla accept patients with Medicare?
Yes, Dr. Roopa Rohini Rao-Karlamangla accepts patients with Medicare.